Glutathione-disulfide | hsa00040 | Pentose and glucuronate interconversions | 2.33E-04 | 2 | P15121, P14550 | AKR1B1, AKR1A1 | More | |
Glutathione-disulfide | hsa00120 | Primary bile acid biosynthesis | 3.72E-02 | 2 | P22680, P22307 | CYP7A1, SCP2 | More | |
Glutathione-disulfide | hsa00480 | Glutathione metabolism | 2.31E-02 | 1 | P22352 | GPX3 | More | |
Glutathione-disulfide | hsa00510 | N-Glycan biosynthesis | 3.01E-02 | 1 | O94777 | DPM2 | More | |
Glutathione-disulfide | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 1.91E-02 | 1 | Q9NY97 | B3GNT2 | More | |
Glutathione-disulfide | hsa00561 | Glycerolipid metabolism | 2.62E-02 | 2 | P15121, P14550 | AKR1B1, AKR1A1 | More | |
Glutathione-disulfide | hsa00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 1.51E-02 | 1 | O94777 | DPM2 | More | |
Glutathione-disulfide | hsa00590 | Arachidonic acid metabolism | 6.63E-03 | 1 | P22352 | GPX3 | More | |
Glutathione-disulfide | hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 3.78E-02 | 1 | Q9NY97 | B3GNT2 | More | |
Glutathione-disulfide | hsa00630 | Glyoxylate and dicarboxylate metabolism | 6.94E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | |
Glutathione-disulfide | hsa00790 | Folate biosynthesis | 2.02E-02 | 1 | P15121 | AKR1B1 | More | |
Glutathione-disulfide | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 4.00E-02 | 1 | P09211 | GSTP1 | More | |
Glutathione-disulfide | hsa00983 | Drug metabolism - other enzymes | 1.63E-02 | 2 | P20839, Q16772 | IMPDH1, GSTA3 | More | |
Glutathione-disulfide | hsa01100 | Metabolic pathways | 1.57E-03 | 14 | P35790, Q16772, P36969, P30041, P20839, O94777, P15121, O95861, P14550, Q9UHK6, P04406, Q86VZ5, Q06055, Q9NVH6 | CHKA, GSTA3, GPX4, PRDX6, IMPDH1, DPM2, AKR1B1, BPNT1, AKR1A1, AMACR, GAPDH, SGMS1, ATP5G2, TMLHE | More | |
Glutathione-disulfide | hsa01210 | 2-Oxocarboxylic acid metabolism | 1.91E-02 | 1 | P50213 | IDH3A | More | |
Glutathione-disulfide | hsa01524 | Platinum drug resistance | 4.67E-02 | 4 | Q13489, P98170, P78417, P43246 | BIRC3, BIRC4, GSTO1, MSH2 | More | |
Glutathione-disulfide | hsa03010 | Ribosome | 2.25E-04 | 5 | P40429, Q07020, P27635, P05386, P62249 | RPL13A, RPL18, RPL10, RPLP1, RPS16 | More | |
Glutathione-disulfide | hsa03040 | Spliceosome | 4.87E-03 | 7 | O43143, P08579, P26368, Q13595, Q07955, P84103, Q13243 | DHX15, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS3, SFRS5 | More | |
Glutathione-disulfide | hsa04062 | Chemokine signaling pathway | 3.81E-02 | 6 | P07948, P62873, P63218, P50151, P43250, Q13009 | LYN, GNB1, GNG5, GNG10, GRK6, TIAM1 | More | |
Glutathione-disulfide | hsa04217 | Necroptosis | 1.37E-02 | 6 | P01568, Q13489, P98170, P08238, P15104, P21796 | IFNA21, BIRC3, BIRC4, HSP90AB1, GLUL, VDAC1 | More | |
Glutathione-disulfide | hsa04371 | Apelin signaling pathway | 3.23E-04 | 7 | P62873, P63218, P50151, Q13485, P84022, Q16566, P0DP23 | GNB1, GNG5, GNG10, SMAD4, SMAD3, CAMK4, CALM1 | More | |
Glutathione-disulfide | hsa04390 | Hippo signaling pathway | 4.35E-02 | 2 | P63261, O15105 | ACTG1, SMAD7 | More | |
Glutathione-disulfide | hsa04530 | Tight junction | 4.35E-02 | 2 | P63261, Q92974 | ACTG1, ARHGEF2 | More | |
Glutathione-disulfide | hsa04713 | Circadian entrainment | 1.78E-03 | 5 | O15399, P0DP23, P62873, P63218, P50151 | GRIN2D, CALM1, GNB1, GNG5, GNG10 | More | |
Glutathione-disulfide | hsa04720 | Long-term potentiation | 2.33E-02 | 3 | Q16566, P0DP23, O15399 | CAMK4, CALM1, GRIN2D | More | |
Glutathione-disulfide | hsa04724 | Glutamatergic synapse | 1.11E-03 | 5 | O15399, P62873, P63218, P50151, P15104 | GRIN2D, GNB1, GNG5, GNG10, GLUL | More | |
Glutathione-disulfide | hsa04725 | Cholinergic synapse | 9.51E-03 | 4 | P62873, P63218, P50151, Q16566 | GNB1, GNG5, GNG10, CAMK4 | More | |
Glutathione-disulfide | hsa04726 | Serotonergic synapse | 2.38E-02 | 4 | P62873, P63218, P50151, P09917 | GNB1, GNG5, GNG10, ALOX5 | More | |
Glutathione-disulfide | hsa04727 | GABAergic synapse | 2.45E-03 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | |
Glutathione-disulfide | hsa04744 | Phototransduction | 6.94E-03 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | |
Glutathione-disulfide | hsa04918 | Thyroid hormone synthesis | 3.62E-02 | 1 | P22352 | GPX3 | More | |
Glutathione-disulfide | hsa05010 | Alzheimer disease | 2.05E-03 | 3 | Q06055, P04406, P62195 | ATP5G2, GAPDH, PSMC5 | More | |
Glutathione-disulfide | hsa05012 | Parkinson disease | 2.21E-02 | 2 | Q06055, P62195 | ATP5G2, PSMC5 | More | |
Glutathione-disulfide | hsa05014 | Amyotrophic lateral sclerosis | 3.35E-02 | 2 | Q06055, P62195 | ATP5G2, PSMC5 | More | |
Glutathione-disulfide | hsa05016 | Huntington disease | 2.48E-02 | 2 | Q06055, P62195 | ATP5G2, PSMC5 | More | |
Glutathione-disulfide | hsa05020 | Prion disease | 3.20E-02 | 2 | Q06055, P62195 | ATP5G2, PSMC5 | More | |
Glutathione-disulfide | hsa05022 | Pathways of neurodegeneration - multiple diseases | 4.69E-02 | 2 | Q06055, P62195 | ATP5G2, PSMC5 | More | |
Glutathione-disulfide | hsa05032 | Morphine addiction | 1.34E-02 | 4 | P62873, P63218, P50151, P43250 | GNB1, GNG5, GNG10, GRK6 | More | |
Glutathione-disulfide | hsa05034 | Alcoholism | 3.87E-03 | 7 | O15399, Q16566, P0DP23, P62873, P63218, P50151, Q93079 | GRIN2D, CAMK4, CALM1, GNB1, GNG5, GNG10, H2BC9 | More | |
Glutathione-disulfide | hsa05163 | Human cytomegalovirus infection | 2.00E-02 | 6 | P62873, P63218, P50151, P0DP23, P30101, P01568 | GNB1, GNG5, GNG10, CALM1, PDIA3, IFNA21 | More | |
Glutathione-disulfide | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 2.00E-02 | 6 | P01568, P62873, P63218, P50151, P07948, P0DP23 | IFNA21, GNB1, GNG5, GNG10, LYN, CALM1 | More | |
Glutathione-disulfide | hsa05168 | Herpes simplex virus 1 infection | 4.43E-02 | 8 | P01568, Q07955, P84103, Q13243, Q13489, P30101, Q13398, Q9NZL3 | IFNA21, SFRS1, SFRS3, SFRS5, BIRC3, PDIA3, ZNF211, ZNF224 | More | |
Glutathione-disulfide | hsa05170 | Human immunodeficiency virus 1 infection | 1.83E-02 | 7 | P62873, P63218, P50151, P0DP23, P30101, P01568, P23528 | GNB1, GNG5, GNG10, CALM1, PDIA3, IFNA21, CFL1 | More | |
Glutathione-disulfide | hsa05171 | Coronavirus disease - COVID-19 | 3.87E-04 | 5 | P62249, P40429, P27635, Q07020, P05386 | RPS16, RPL13A, RPL10, RPL18, RPLP1 | More | |
Glutathione-disulfide | hsa05200 | Pathways in cancer | 3.99E-04 | 15 | Q13751, P08238, P43246, P84022, Q13485, Q13489, P98170, P62873, P63218, P50151, P78417, O75293, P0DP23, P01568, P01042 | LAMB3, HSP90AB1, MSH2, SMAD3, SMAD4, BIRC3, BIRC4, GNB1, GNG5, GNG10, GSTO1, GADD45B, CALM1, IFNA21, KNG1 | More | |
Glutathione-disulfide | hsa05204 | Chemical carcinogenesis | 4.00E-02 | 1 | P09211 | GSTP1 | More | |
Glutathione-disulfide | hsa05210 | Colorectal cancer | 4.67E-02 | 4 | P84022, Q13485, P43246, O75293 | SMAD3, SMAD4, MSH2, GADD45B | More | |
Glutathione-disulfide | hsa05212 | Pancreatic cancer | 3.28E-02 | 3 | P84022, Q13485, O75293 | SMAD3, SMAD4, GADD45B | More | |
Glutathione-disulfide | hsa05214 | Glioma | 3.28E-02 | 3 | P0DP23, Q16566, O75293 | CALM1, CAMK4, GADD45B | More | |
Glutathione-disulfide | hsa05222 | Small cell lung cancer | 3.80E-02 | 4 | Q13751, Q13489, P98170, O75293 | LAMB3, BIRC3, BIRC4, GADD45B | More | |
Glutathione-disulfide | hsa05415 | Diabetic cardiomyopathy | 1.09E-02 | 2 | Q06055, P04406 | ATP5G2, GAPDH | More | |